Sofia Zhidro

Senior Director Quality at Vigil Neuro

Sofia Zhidro, MBA, CQA has extensive experience in the field of quality assurance and compliance. Sofia is currently serving as a Senior Director of Quality at Vigil Neuroscience, where they have been since February 2023. Prior to this, they were the Director of Quality Assurance at the same company starting from February 2021.

Before joining Vigil Neuroscience, Sofia held various roles at Verastem Oncology. Sofia worked as an Associate Director of Quality from March 2020 to February 2021 and as a Senior Manager of Quality Control and Compliance from September 2018 to March 2020. In these positions, they were responsible for overseeing compliance, implementing internal audit programs, and leading FDA inspection preparation.

Earlier in their career, Sofia worked at Boston Technology Research Corp as a Principal Consultant from February 2016 to October 2017. In this role, they managed projects related to FDA readiness and software development validation. Sofia also worked as a Project Quality Manager at the same company from February 2016 to September 2016.

Sofia's work experience also includes a role as a Quality Control Biochemistry Associate at Merrimack Pharmaceuticals from July 2014 to January 2016, where they assisted in market research and validation of computer systems for biochemistry. Sofia started their career at Lonza, where they held positions as a QC Analyst II (Biochemistry/Analytical) from December 2011 to March 2014 and as a QC Analyst I (Microbiology) from November 2010 to December 2011.

Overall, Sofia Zhidro has demonstrated expertise in quality assurance, compliance, FDA readiness, and project management throughout their career.

Sofia Zhidro, MBA, CQA has a Bachelor of Science (BS) degree in Biology/Biotechnology from Worcester State University, which they completed from 2005 to 2009. Sofia later pursued their Master of Business Administration (MBA) degree with a focus on Entrepreneurship and Innovation at Worcester Polytechnic Institute from 2012 to 2015.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices


Vigil Neuro

Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.


Employees

51-200

Links